|
Paul Zhang has an M.B.A. degree from Cornell University's Johnson Graduate School of Management, an M.S. degree from Rutgers University and an B.S. degree from Nanjing University. Mr. Zhang spent seven years in the pharmaceutical industry with Bristol-Myers Squibb, Knoll Pharma, and Pharmacia. During this period, Mr. Zhang’s diverse responsibilities included oncology drug discovery, market research and strategic planning in pain management and obesity, and pipeline valuation for primary care products. In his years at Easton Associates, Mr. Zhang has focused on assisting biopharmaceutical clients in a wide range of topics including new product launch studies, therapeutic area franchise assessments, market forecasting, strategy development, due diligence and M&A valuations. Examples of his recent engagements include: (1) leading a team analyzing the market potential for a novel anticoagulant, (2) developing a simulation model to project the market outlook for ophthalmic pharmaceuticals, and (3) identifying licensing and acquisition targets for a leading global pharmaceutical client. His therapeutic areas of expertise include ophthalmology, pain management, gastroenterology and oncology. | 